Connection
Robert Scheinman to Leukocytes
This is a "connection" page, showing publications Robert Scheinman has written about Leukocytes.
|
|
Connection Strength |
|
 |
|
 |
|
0.169 |
|
|
|
-
Gifford G, Vu VP, Banda NK, Holers VM, Wang G, Groman EV, Backos D, Scheinman R, Moghimi SM, Simberg D. Complement therapeutics meets nanomedicine: overcoming human complement activation and leukocyte uptake of nanomedicines with soluble domains of CD55. J Control Release. 2019 05 28; 302:181-189.
Score: 0.147
-
Thakur A, Scheinman RI, Rao VR, Kompella UB. Pazopanib, a multitargeted tyrosine kinase inhibitor, reduces diabetic retinal vascular leukostasis and leakage. Microvasc Res. 2011 Nov; 82(3):346-50.
Score: 0.022